Page last updated: 2024-09-04

vatalanib and Prostatic Neoplasms

vatalanib has been researched along with Prostatic Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abou El Ella, DA; Abou-Seri, SM; Ali, MM; Eldehna, WM	1
Cserepes T, M; Döme, B; Rényi-Vámos, F; Török, S	1
Dai, J; Keller, ET; Keller, JM; Kitagawa, Y; Nor, J; Yao, Z; Zhang, J	1

Reviews

1 review(s) available for vatalanib and Prostatic Neoplasms

Article	Year
[Nintedanib (BIBF 1120) in the treatment of solid cancers: an overview of biological and clinical aspects]. Magyar onkologia, 2012, Volume: 56, Issue:3 Topics: Animals; Antineoplastic Agents; Axitinib; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Colorectal Neoplasms; Digestive System; Enzyme Inhibitors; Female; Genital Neoplasms, Female; Humans; Imidazoles; Indazoles; Indoles; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms; Niacinamide; Oligonucleotides; Phenylurea Compounds; Phthalazines; Piperidines; Prostatic Neoplasms; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Quinazolines; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sorafenib; Sulfonamides; Xenograft Model Antitumor Assays	2012

Article

Year

[Nintedanib (BIBF 1120) in the treatment of solid cancers: an overview of biological and clinical aspects].

Magyar onkologia, 2012, Volume: 56, Issue:3

Topics: Animals; Antineoplastic Agents; Axitinib; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Colorectal Neoplasms; Digestive System; Enzyme Inhibitors; Female; Genital Neoplasms, Female; Humans; Imidazoles; Indazoles; Indoles; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms; Niacinamide; Oligonucleotides; Phenylurea Compounds; Phthalazines; Piperidines; Prostatic Neoplasms; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Quinazolines; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sorafenib; Sulfonamides; Xenograft Model Antitumor Assays

2012

Other Studies

2 other study(ies) available for vatalanib and Prostatic Neoplasms

Article	Year
1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation. European journal of medicinal chemistry, 2016, Jan-01, Volume: 107 Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Male; Molecular Docking Simulation; Phthalazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2	2016
Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer research, 2005, Dec-01, Volume: 65, Issue:23 Topics: Alkaline Phosphatase; Animals; Binding Sites; Bone Neoplasms; Cell Line, Tumor; Humans; Male; Mice; Mice, SCID; Osteoblasts; Osteocalcin; Phthalazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyridines; RNA, Messenger; Signal Transduction; Vascular Endothelial Growth Factor A	2005

Article

Year

1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation.

European journal of medicinal chemistry, 2016, Jan-01, Volume: 107

Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Male; Molecular Docking Simulation; Phthalazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2

2016

Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.

Cancer research, 2005, Dec-01, Volume: 65, Issue:23

Topics: Alkaline Phosphatase; Animals; Binding Sites; Bone Neoplasms; Cell Line, Tumor; Humans; Male; Mice; Mice, SCID; Osteoblasts; Osteocalcin; Phthalazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Pyridines; RNA, Messenger; Signal Transduction; Vascular Endothelial Growth Factor A

2005